Monoclonal antibodies blocking CGRP for prevention of migraine
Introduction and purpose Monoclonal antibodies blocking calcitonin gene-related peptide (CGRP) are a novel treatment strategy developed specifically for prevention of migraine. Four drugs belong to this group: eptinezumab, fremanezumab and galcanezumab, which bind to the peptide; and erenumab, w...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Kazimierz Wielki University
2023-04-01
|
| Seri Bilgileri: | Journal of Education, Health and Sport |
| Konular: | |
| Online Erişim: | https://apcz.umk.pl/JEHS/article/view/43098 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|